￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

Oncology

Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
Can ROS1-mutated lung cancer that is resistant to crizotinib continue to be treated with entrectinib?

2025-10-19 11:44:20

Check Details
New immune therapy for lung cancer-PD-1 inhibitor nivolumab

2025-10-19 11:44:20

Check Details
Can ceritinib treat lung cancer patients who are resistant to alectinib?

2025-10-19 11:44:20

Check Details
Has the PD-1 inhibitor nivolumab been approved for marketing in China?

2025-10-19 11:44:20

Check Details
Entrectinib has significant efficacy in the treatment of ROS1-positive metastatic non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Safety and efficacy of nivolumab monotherapy in the treatment of advanced or metastatic squamous NSCLC_ Kanghule

2025-10-19 11:44:20

Check Details
How much does the PD-1 inhibitor nivolumab cost? Where can I buy it?

2025-10-19 11:44:20

Check Details
Is nivolumab a Pd-1 inhibitor?

2025-10-19 11:44:20

Check Details
Ceritinib first-line treatment of ALK-positive advanced non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Safety, tolerability and efficacy of nivolumab in advanced non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Entrectinib can effectively treat ROS1-positive non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Dosage and administration method of ceritinib in lung cancer

2025-10-19 11:44:20

Check Details
Category
相关知识